[Reality and hope: a critical approach to an antiemetic drug]

Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2025

From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development.

ESMO open·2025

2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2023

Nutrition education in medical schools (NEMS) project: Promoting clinical nutrition in medical schools - Perspectives from different actors.

Clinical nutrition (Edinburgh, Scotland)·2022

Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries.

ESMO open·2021

Supportive care in patients with cancer during the COVID-19 pandemic.

ESMO open·2021

[Sarcopenia in gastrointestinal oncology: Diagnostic criteria, clinical implications and management].

Bulletin du cancer·2026

[Tenosyovial giant cell tumor (TGCT): From the physiopathology to the emergence of new targeted therapies].

Bulletin du cancer·2026

[Management of venous thromboembolism in children with acute lymphoblastic leukemia: Recommendations from the harmonization workshops of the Leukemia Committee of the French Society for Childhood Cancer (SFCE)].

Bulletin du cancer·2026

Hospitalization at home use analysis for immune checkpoint inhibitors administrations in France: Care pathways, costs and development opportunities.

Bulletin du cancer·2026

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Bulletin du cancer·2026

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

Bulletin du cancer·2026

Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer's disease.

The Journal of pharmacy and pharmacology·2026

Predictive Analysis on the Mechanism of Dendrobium officinale Polysaccharides in Treating Hepatic Fibrosis via Network Pharmacology and Molecular Docking.

BioMed research international·2026

Supramolecular strategy in traditional Chinese medicine processing: Mechanistic insights mediated by self-assembly.

Acta pharmaceutica Sinica. B·2026

Deciphering the interaction landscape of NDM-1 with a novel β-lactam-based inhibitor: implications for rational drug design.

In silico pharmacology·2026

Exploration of Bacopa monnieri-derived Green Ligands for Targeted IDH1 Inhibition in Glioblastoma.

Current drug discovery technologies·2026

Identification and 3D Modeling of Novel Drug Targets in Leishmania Major: An in-silico Approach.

Infectious disorders drug targets·2026

Related Experiment Videos

[Reality and hope: a critical approach to an antiemetic drug]

Related Concept Videos

Personalised antiemetic prophylaxis with NEPA for patients at high risk of chemotherapy-induced nausea and vomiting receiving moderately emetogenic chemotherapy: results from the randomised, multinational MyRisk trial.

From toxicity assessment to adaptive safety care: implementing comprehensive fast-track safety evaluation for anticancer drug development.

2023 updated MASCC/ESMO consensus recommendations: prevention of nausea and vomiting following high-emetic-risk antineoplastic agents.

Nutrition education in medical schools (NEMS) project: Promoting clinical nutrition in medical schools - Perspectives from different actors.

Organized breast cancer screening not only reduces mortality from breast cancer but also significantly decreases disability-adjusted life years: analysis of the Global Burden of Disease Study and screening programme availability in 130 countries.

Supportive care in patients with cancer during the COVID-19 pandemic.

[Sarcopenia in gastrointestinal oncology: Diagnostic criteria, clinical implications and management].

[Tenosyovial giant cell tumor (TGCT): From the physiopathology to the emergence of new targeted therapies].

[Management of venous thromboembolism in children with acute lymphoblastic leukemia: Recommendations from the harmonization workshops of the Leukemia Committee of the French Society for Childhood Cancer (SFCE)].

Hospitalization at home use analysis for immune checkpoint inhibitors administrations in France: Care pathways, costs and development opportunities.

[Oncogenetics and molecular tumor boards in private practice: Specificities and perspectives].

Targeting TP53 in triple-negative breast cancer: Molecular pathogenesis, therapeutic implications, and emerging pharmacological strategies.

Integrating network pharmacology and experimental validation to uncover the mechanisms of Ganoderma lucidum in ameliorating neuroinflammation in Alzheimer's disease.

Predictive Analysis on the Mechanism of Dendrobium officinale Polysaccharides in Treating Hepatic Fibrosis via Network Pharmacology and Molecular Docking.

Supramolecular strategy in traditional Chinese medicine processing: Mechanistic insights mediated by self-assembly.

Deciphering the interaction landscape of NDM-1 with a novel β-lactam-based inhibitor: implications for rational drug design.

Exploration of Bacopa monnieri-derived Green Ligands for Targeted IDH1 Inhibition in Glioblastoma.

Identification and 3D Modeling of Novel Drug Targets in Leishmania Major: An in-silico Approach.

Related Experiment Videos

[Reality and hope: a critical approach to an antiemetic drug]

Related Concept Videos

Related Articles